Bioecolians是一种商业α -低聚糖,对IBS-C症状患者肠功能的影响

Yvergnaux Florent, L. Laurent, Saguet Thibaut
{"title":"Bioecolians是一种商业α -低聚糖,对IBS-C症状患者肠功能的影响","authors":"Yvergnaux Florent, L. Laurent, Saguet Thibaut","doi":"10.35248/2155-9600.21.11.787","DOIUrl":null,"url":null,"abstract":"Aim: The purpose of the study was to evaluate the effect of the consumption of BioEcolians, a commercial α-gluco-oligosaccharide, on IBS-c symptoms and various strains of the gut microbiome. Methods: 50 subjects participated in a double blind placebo control study. Subjects consumed 2 gr/day of BioEcolians or placebo capsules for 28 days and were evaluated for IBS-C symptoms (abdominal pain, bloating, discomfort and stool consistency). Fecal exams were performed in order to evaluate changes in the gut microbiom. Results: BioEcolians treatment resulted in a progressive amelioration of IBS-C symptoms with a statistically significant improvement from day 14 to day 28. Stool frequency showed a progressive and statistically significant improvement with a mean increment of 1.6 complete spontaneous bowel movements (CSBM) in the BioEcolians group. Stool consistency significantly improved in both groups but BioEcolians treatment resulted in higher scores and showed a progressive increment (100% improvement versus 50% in the placebo group). BioEcolians intake resulted in a significant increase in the fecal counts of Bifidobacterium longum and Bifidobacterium animalis and all evaluated Lactobacilli strains. The change was statistically significant compared to baseline. No significant modification of calprotectin and lactoferrin was recorded following BioEcolians or placebo intake. The level of fecal Human Beta-Defensin 2 (HBD-2) increased in both treatment groups but and statistically significant only in the BioEcolians group. Conclusions: The progressive amelioration of symptoms in IBS-C subjects recorded throughout the 28 days of the study with the modification of the content of fecal Bifidobacteria and Lactobacilli suggests that BioEcolians could serve as a beneficial dietary agent against IBS-C symptoms. Further investigations are required in order to evaluate the improvement of symptoms in healthy population.","PeriodicalId":16764,"journal":{"name":"Journal of Nutrition and Food Sciences","volume":"39 1","pages":"1-8"},"PeriodicalIF":0.0000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The Effect of Bioecolians, A Commercial Alpha-Gluco-Oligosaccharide, on Bowel Function in Subjects with IBS-C Symptoms\",\"authors\":\"Yvergnaux Florent, L. Laurent, Saguet Thibaut\",\"doi\":\"10.35248/2155-9600.21.11.787\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Aim: The purpose of the study was to evaluate the effect of the consumption of BioEcolians, a commercial α-gluco-oligosaccharide, on IBS-c symptoms and various strains of the gut microbiome. Methods: 50 subjects participated in a double blind placebo control study. Subjects consumed 2 gr/day of BioEcolians or placebo capsules for 28 days and were evaluated for IBS-C symptoms (abdominal pain, bloating, discomfort and stool consistency). Fecal exams were performed in order to evaluate changes in the gut microbiom. Results: BioEcolians treatment resulted in a progressive amelioration of IBS-C symptoms with a statistically significant improvement from day 14 to day 28. Stool frequency showed a progressive and statistically significant improvement with a mean increment of 1.6 complete spontaneous bowel movements (CSBM) in the BioEcolians group. Stool consistency significantly improved in both groups but BioEcolians treatment resulted in higher scores and showed a progressive increment (100% improvement versus 50% in the placebo group). BioEcolians intake resulted in a significant increase in the fecal counts of Bifidobacterium longum and Bifidobacterium animalis and all evaluated Lactobacilli strains. The change was statistically significant compared to baseline. No significant modification of calprotectin and lactoferrin was recorded following BioEcolians or placebo intake. The level of fecal Human Beta-Defensin 2 (HBD-2) increased in both treatment groups but and statistically significant only in the BioEcolians group. Conclusions: The progressive amelioration of symptoms in IBS-C subjects recorded throughout the 28 days of the study with the modification of the content of fecal Bifidobacteria and Lactobacilli suggests that BioEcolians could serve as a beneficial dietary agent against IBS-C symptoms. Further investigations are required in order to evaluate the improvement of symptoms in healthy population.\",\"PeriodicalId\":16764,\"journal\":{\"name\":\"Journal of Nutrition and Food Sciences\",\"volume\":\"39 1\",\"pages\":\"1-8\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Nutrition and Food Sciences\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.35248/2155-9600.21.11.787\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Nutrition and Food Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.35248/2155-9600.21.11.787","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

目的:本研究的目的是评估食用BioEcolians(一种商业α-低聚葡萄糖)对IBS-c症状和肠道微生物群不同菌株的影响。方法:50名受试者参加双盲安慰剂对照研究。受试者每天服用2克BioEcolians或安慰剂胶囊,持续28天,并评估IBS-C症状(腹痛、腹胀、不适和大便一致性)。进行粪便检查以评估肠道微生物组的变化。结果:biecolians治疗导致IBS-C症状逐渐改善,从第14天到第28天有统计学意义的改善。在biecolians组中,大便频率显示出进步性和统计学上显著的改善,平均增加1.6次完全自发排便(CSBM)。两组的粪便稠度均有显著改善,但BioEcolians治疗后得分更高,且呈渐进式增长(100%改善,而安慰剂组为50%)。摄入生物生态菌导致长双歧杆菌和动物双歧杆菌以及所有评估的乳酸杆菌菌株的粪便计数显著增加。与基线相比,这一变化具有统计学意义。摄入BioEcolians或安慰剂后,钙保护蛋白和乳铁蛋白没有显著变化。在两个治疗组中,粪便中人类β -防御素2 (HBD-2)的水平都有所增加,但只有在生物生态菌组中才有统计学意义。结论:在28天的研究中,通过改变粪便中双歧杆菌和乳酸杆菌的含量,IBS-C受试者的症状逐渐改善,这表明BioEcolians可能是一种有益的饮食剂,可以治疗IBS-C症状。需要进一步调查,以评估健康人群中症状的改善情况。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
The Effect of Bioecolians, A Commercial Alpha-Gluco-Oligosaccharide, on Bowel Function in Subjects with IBS-C Symptoms
Aim: The purpose of the study was to evaluate the effect of the consumption of BioEcolians, a commercial α-gluco-oligosaccharide, on IBS-c symptoms and various strains of the gut microbiome. Methods: 50 subjects participated in a double blind placebo control study. Subjects consumed 2 gr/day of BioEcolians or placebo capsules for 28 days and were evaluated for IBS-C symptoms (abdominal pain, bloating, discomfort and stool consistency). Fecal exams were performed in order to evaluate changes in the gut microbiom. Results: BioEcolians treatment resulted in a progressive amelioration of IBS-C symptoms with a statistically significant improvement from day 14 to day 28. Stool frequency showed a progressive and statistically significant improvement with a mean increment of 1.6 complete spontaneous bowel movements (CSBM) in the BioEcolians group. Stool consistency significantly improved in both groups but BioEcolians treatment resulted in higher scores and showed a progressive increment (100% improvement versus 50% in the placebo group). BioEcolians intake resulted in a significant increase in the fecal counts of Bifidobacterium longum and Bifidobacterium animalis and all evaluated Lactobacilli strains. The change was statistically significant compared to baseline. No significant modification of calprotectin and lactoferrin was recorded following BioEcolians or placebo intake. The level of fecal Human Beta-Defensin 2 (HBD-2) increased in both treatment groups but and statistically significant only in the BioEcolians group. Conclusions: The progressive amelioration of symptoms in IBS-C subjects recorded throughout the 28 days of the study with the modification of the content of fecal Bifidobacteria and Lactobacilli suggests that BioEcolians could serve as a beneficial dietary agent against IBS-C symptoms. Further investigations are required in order to evaluate the improvement of symptoms in healthy population.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Eating Disorders and the Internet: A Descriptive Cross-Sectional Study Monitoring The Pro Ana Phenomenon in An Italian Sample. Assessing US Registered Dietitians Knowledge and Perceptions of a Gluten-Free Diet: A Mixed Methods Approach Metabolic Disorder Perturb Renal Homeostasis Journal of Nutrition & Food Science Highlights Study of the Morphological and Agricultural Characteristics of Gvara-Khutsubani Wine and Table Breeds and the Potential of Wines Obtained from them
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1